Soleno Therapeutics to Present at the Cantor Global Healthcare Conference

<p>REDWOOD CITY, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the Cantor Global Healthcare Conference on Tuesday, September 26, 2023 at 8:10 AM Eastern Time. […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/soleno-therapeutics-to-present-at-the-cantor-global-healthcare-conference/">Soleno Therapeutics to Present at the Cantor Global Healthcare Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>